cost-effectiveness research

Research in Review

Study: Newer NSCLC Therapies Have Limited Real-World Survival Benefit, High Costs

02/14/2017

JCP Editors

Therapies recently approved to treat advanced-stage non-small cell lung cancer (NSCLC) confer an average of 1.5-month survival increase and an $8,000 increase in outpatient spending per patient, according to a study...

...

02/14/2017

Journal of Clinical Pathways

Research in Review

Surveillance Superior to Standard Care for Melanoma

11/01/2016

JCP Editors

Specialized surveillance may be more cost effective and lead to fewer invasive procedures compared with standard care for patients with a high risk of melanoma, according to a study published in the Journal of...

...

11/01/2016

Journal of Clinical Pathways

Research in Review

Response-Guided Neoadjuvant Chemotherapy Cost Effective for Breast Cancer

09/07/2016

JCP Editors

Response-guided neoadjuvant chemotherapy (RG-NACT) is more cost effective than conventional NACT for estrogen receptor (ER)-positive/human epidermal growth factor receptor 2 (HER2)-negative breast cancer, according...

...

09/07/2016

Journal of Clinical Pathways

Research in Review

Trastuzumab Cost Effectiveness Varies Based on Hormone Receptor Status

09/06/2016

JCP Editors

How cost effective trastuzumab is for human epidermal growth factor receptor 2 (HER2)-positive breast cancer depends largely on patients’ age and hormone receptor status, according to a review published in PLOS...

How...

09/06/2016

Journal of Clinical Pathways

Research in Review

Bortezomib Regimen More Cost Effective Than Current Standard for Mantle Cell Lymphoma

08/05/2016

JCP Editors

Bortezomib plus rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (VR-CAP) may be a more cost-effective treatment option in the United Kingdom for patients with previously untreated mantle cell...

...

08/05/2016

Journal of Clinical Pathways

Research in Review

Chemotherapy Followed By Surgery Improves Lung Cancer Outcomes Compared With Chemoradiation Alone

07/26/2016

JCP Editors

Preoperative chemotherapy followed by resection may produce better survival outcomes than chemoradiation alone for patients with lung cancer, according to a study published in Medical Science Monitor. Current...

...

07/26/2016

Journal of Clinical Pathways

Research in Review

Cost-Effectiveness of Two NSCLC Treatments Compared

07/15/2016

JCP Editors

Compared with docetaxel, nivolumab is not a cost-effective treatment option for nonsquamous non-small cell lung cancer unless its price is reduced or it is used after programmed death ligand 1 (PD-L1) testing,...

...

07/15/2016

Journal of Clinical Pathways

Research in Review

Cisplatin and Paclitaxel Most Cost-Effective Chemotherapy Combination for Cervical Cancer

06/28/2016

JCP Editors

Cisplatin and paclitaxel may be the most cost-effective chemotherapy combination for women with advanced, persistent, or recurrent cervical cancer, according to research published in Dovepress. In the study,...

...

06/28/2016

Journal of Clinical Pathways

Research in Review

Variation in Regimen Cost-Effectiveness for Metastatic Colon Cancer

06/24/2016

JCP Editors

A study published in the Journal of Managed Care & Specialty Pharmacy has shown that outcomes for metastatic colon cancer and the cost of care can both vary significantly based on which therapies are used in...

A...

06/24/2016

Journal of Clinical Pathways

Significant Cost Variation in Breast Cancer Chemotherapy

06/13/2016

JCP Editors

A study presented at the 2016 American Society of Clinical Oncology Annual Meeting (June 3-7; Chicago, IL) has found that the costs associated with different breast cancer chemotherapy regimens can vary...

A...

06/13/2016

Journal of Clinical Pathways